ARTICLE | Clinical News
ALX1-11: Began Phase III trial
February 22, 2000 8:00 AM UTC
NPS Pharmaceuticals Inc. (NPSP; TSE:NX), Salt Lake City, Utah Product: ALX1-11 Business: Musculoskeletal Therapeutic category: Hormone replacement Target: PTH receptor Description: Injectable recombi...